The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The PARADIGM trial: A phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC).
Robert I. Haddad
Disclosure not yet available
Guilherme Rabinowits
Disclosure not yet available
Roy B. Tishler
Disclosure not yet available
Douglas Adkins
Disclosure not yet available
Fadlo Raja Khuri
Disclosure not yet available
Joseph Clark
Disclosure not yet available
Jochen H. Lorch
Disclosure not yet available
Sewanti Atul Limaye
Disclosure not yet available
Lori J. Wirth
Disclosure not yet available
Anne O'Neill
Disclosure not yet available
Sarah Riley
Disclosure not yet available
Marshall R. Posner
Disclosure not yet available